February 2018

Perspective 
Recent market status and trends of fractionated plasma products
Matthew Hotchko, Patrick Robert
Annals of Blood  
2018,  
3:
19  
Editorial 
Cardiovascular genetics: a super-bright or over-hyped perspective?
Giuseppe Lippi, Emmanuel J. Favaloro
Annals of Blood  
2018,  
3:
18  
Viewpoint 
Labeling tubes before collection threatens patient safety
Dennis J. Ernst, George A. Fritsma, David L. McGlasson
Annals of Blood  
2018,  
3:
16  
Perspective 
Plasma fractionation in China: progress and challenges
Ya Wang, Zongkui Wang, Bin Liu, Xiaoqian Huang, Wenhui Li, Changqing Li
Annals of Blood  
2018,  
3:
15  
Review Article 
Building blocks of the viral safety margins of industrial plasma products
Thomas R. Kreil
Annals of Blood  
2018,  
3:
14  
Meet the Professor 
Profs. Erica Wood and Masahiro Satake—sharing, learning and improving
Gin Li
Annals of Blood  
2018,  
3:
13  
Meet the Professor 
Prof. Steve Henry: Kode technology—a magic biological paint
Gin Li
Annals of Blood  
2018,  
3:
12  
Meet the Professor 
Interview with Prof. Martin L. Olsson—meeting the challenge of blood group genotyping to provide safe blood for transfusion
Jessie Zhong, Lynn Ma
Annals of Blood  
2018,  
3:
10  
Original Article 
Diagnosis and management of von Willebrand disease in Slovakia
Peter Kubisz, Juraj Sokol, Tomas Simurda, Ivana Plamenova, Miroslava Dobrotova, Pavol Holly, Ingrid Skornova, Jan Stasko
Annals of Blood  
2018,  
3:
9  
Meet the Professor 
Interview with Prof. Evan Martin Bloch—public and clinical awareness of babesiosis is critical
Jessie S. Zhong, Lynn Ma
Annals of Blood  
2018,  
3:
8